Sunday - February 01, 2026

Best Skincare for Men: Strive Recognized as a Leading Men’s Brand for Ingredient Transparency and Science-Backed Formulas

Strive logo — the chemist-founded men’s skincare brand recognized among the Best Skincare Brands for Men of 2026 for ingredient transparency and science-backed formulations. Strive, a chemist-founded men’s skincare brand, has been recognized among the Best Skincare Brands for Men … Continue reading

Persistent Corneal Epithelial Defects Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Persistent Corneal Epithelial Defects Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Persistent Corneal Epithelial Defects pipeline landscape. It covers the Persistent Corneal Epithelial Defects pipeline drug profiles, including clinical and nonclinical … Continue reading

Autistic Disorder Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Autistic Disorder Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Autistic Disorder pipeline landscape. It covers the Autistic Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Alopecia Areata Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Alopecia Areata Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia Areata pipeline landscape. It covers the Alopecia Areata pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading